Atara Biotherapeutics
ATRA
ATRA
84 hedge funds and large institutions have $360M invested in Atara Biotherapeutics in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
27% less capital invested
Capital invested by funds: $493M → $360M (-$132M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
84
Holding in Top 10
1
Calls
$1.44M
Puts
$836K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$5.75M | |
| 3 | +$4.9M | |
| 4 |
RI
RTW Investments
New York
|
+$3.7M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$3.16M |
Top Sellers
| 1 | -$8.94M | |
| 2 | -$3.68M | |
| 3 | -$2.67M | |
| 4 |
Goldman Sachs
New York
|
-$2.61M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.26M |